Balance between angiotensin converting enzyme and angiotensin converting enzyme 2 in patients with chronic heart failure
Aim: It has been reported that angiotensin converting enzyme 2 (ACE2) is an endogenous counter-regulator of the renin–angiotensin–aldosterone system. However, angiotensin converting enzyme (ACE)/ACE2 balance in the development of human heart failure is not well established. Methods: Here we evaluate...
Main Authors: | Jiang Wang, Nan Li, Feng Gao, Rong Song, Shanjun Zhu, Zhaohua Geng |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2015-09-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/1470320315576257 |
Similar Items
-
Angiotensin-Converting Enzyme and Heart Failure
by: Sara Álvarez-Zaballos, et al.
Published: (2023-07-01) -
Correlation between plasma-soluble angiotensin-converting enzyme 2, anti- angiotensin-converting enzyme 2, and angiotensin-(1–7) in patients with chronic heart failure
by: Yi Gu, et al.
Published: (2019-01-01) -
ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01) -
ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01) -
Angiotensin converting enzyme inhibitors /
by: DeBrue, Anne N.
Published: (c200)